Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

PHLEBI_THROMBOP_OTHER_DEEP_VESSE_LOWER_EXTREMITI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ATC codes for adverse effects of Drugs — ANY Hospital discharge: ICD-10 — I80.29# 1 out of 7 registries used, show all original rules.	125
4. Check minimum number of events None	125
5. Include endpoints None	125
6. Filter based on genotype QC (FinnGen only)	112

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5

NAME	PHLEBI_THROMBOP_OTHER_DEEP_VESSE_LOWER_EXTREMITI
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC	ANY
HD_ICD_10	I8029
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (not available in FinRegistry).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	112	63	49
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	50.92	48.07	54.58

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
115: Matched controls
1150

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

+∞

142.4

115

B01AA03

ATC

warfarin; systemic

18.2

53.0

168

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

16.7

33.8

B01AB04

ATC

dalteparin; parenteral

14.8

14.4

B01AB05

ATC

enoxaparin; parenteral

4.4

14.2

268

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

13.1

9.9

D68.8

ICD-10 Finland

Other specified coagulation defects

24.2

6.8

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40761536) Microorganisms panel - Urine sediment

4.66

9.91

5.4

3.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

115

0.00

4.68

0.0

5.3

—

32.67

—

(1616796) Gas panel - Central venous blood

5.96

4.41

8.9

3.4

—

(3010421) pH of Blood

4.39

3.50

10.2

4.5

7.43

7.42

0.11

(3019225) pH of Specimen

0.00

3.49

0.0

3.8

—

7.37

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2.72

3.43

7.5

4.5

1.23

1.22

mmol/l

0.20

(3013290) Carbon dioxide [Partial pressure] in Blood

4.66

3.40

8.9

3.6

4.86

4.97

kpa

—

(3027315) Oxygen [Partial pressure] in Blood

4.66

3.40

8.9

3.6

8.36

8.82

kpa

—

(40760892) CBC W Ordered Manual Differential panel - Blood

222

1.98

2.77

6.4

5.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

405

1.87

2.76

4.6

4.0

0.00

estimate

-0.00

(3006184) Hemoglobin [Mass/volume] in Capillary blood

3.98

2.73

6.3

2.2

128.11

127.75

g/l

—

(3030467) Casts [#/volume] in Urine by Automated count

292

1.89

2.67

4.4

3.0

0.36

0.38

e6/l

0.04

205

(3035715) Granulocytes [#/volume] in Blood

4.58

2.51

2.3

2.1

6.39

5.53

e9/l

—

(3022806) Fractional oxyhemoglobin in Capillary blood

5.21

2.43

4.5

2.7

88.87

91.34

—

(3035933) Granulocytes/Leukocytes in Blood

3.83

2.41

2.8

2.0

63.00

63.29

—

(3035350) Ketones [Presence] in Urine by Test strip

535

1.79

2.34

4.9

4.0

0.00

14.00

estimate

0.50

116

(3009261) Glucose [Presence] in Urine by Test strip

538

1.77

2.27

5.0

4.1

0.00

estimate

-0.00

106

(3029937) Albumin [Presence] in Urine by Test strip

314

1.77

2.25

5.4

4.1

0.00

estimate

-0.00

102

(3021601) Nitrite [Presence] in Urine by Test strip

531

1.75

2.20

4.9

3.9

0.00

estimate

-0.00

114

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

107

2.05

2.02

6.8

3.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

228

1.77

1.97

2.4

1.8

1.97

1.26

mg/l

0.60

197

(3041096) Erythrocytes [Presence] in Urine by Automated

289

1.71

1.95

4.5

3.4

0.00

estimate

-0.00

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2.07

1.81

3.7

2.8

57.88

61.91

ml/min/173m2

—

(3007853) Bacteria identified in Skin by Aerobe culture

113

1.93

1.74

2.0

1.6

—

(36304419) Bacteria [Presence] in Urine

282

1.64

1.66

4.5

2.9

—

estimate

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.11

1.60

1.0

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

3.43

1.54

9.2

5.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

454

1.56

1.54

8.6

4.8

33.94

35.25

g/l

0.68

434

(3004716) Salmonella sp identified in Stool by Organism specific culture

0.00

1.53

0.0

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

324

1.58

1.52

7.6

3.3

24.76

29.75

u/l

1.98

306

(1761868) Lipid panel - Serum or Plasma

335

1.56

1.47

3.8

3.5

—

(3002582) Erythrocytes [#/volume] in Urine

347

1.54

1.41

4.4

3.2

23.26

216.07

e6/l

0.51

262

(3018095) Leukocytes [#/volume] in Urine

385

1.53

1.39

5.2

3.8

91.28

60.04

e6/l

0.17

272

(3018418) pH of Serum or Plasma

331

1.53

1.36

11.0

4.1

7.40

7.39

0.40

237

(3017181) Myelocytes/Leukocytes in Blood

1.86

1.33

5.9

3.9

0.40

0.79

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2.58

1.32

2.7

1.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.97

1.30

10.1

8.8

24.97

25.00

mmol/l

0.01

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2.31

1.27

2.8

2.4

92.50

93.53

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.86

1.26

1.7

1.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

373

1.49

1.26

4.6

3.1

—

(3015736) pH of Urine

421

1.48

1.24

3.9

3.5

6.25

0.01

235

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

2.70

1.23

7.0

3.7

15.46

12.29

pmol/l

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

214

1.54

1.16

2.4

1.7

611.40

488.82

pmol/l

0.50

182

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

154

1.62

1.15

1.4

1.3

1.12

12.83

u/ml

1.87

(40768443) Skin Pathology biopsy report

2.01

1.10

1.1

1.2

—

(3002179) Metamyelocytes/Leukocytes in Blood

1.75

1.07

6.3

3.8

0.00

0.81

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.80

1.04

2.0

1.6

—

(3026008) Bacteria identified in Urine by Culture

312

1.43

0.99

2.9

3.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.99

0.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.99

0.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.99

0.0

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

0.00

0.98

0.0

1.4

—

3.93

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.00

0.98

0.0

1.4

—

2.21

—

(3021589) Normoblasts [#/volume] in Blood

446

1.40

0.97

23.3

12.6

0.00

e9/l

0.50

359

(3014576) Chloride [Moles/volume] in Serum or Plasma

155

0.55

0.97

8.0

7.6

103.00

103.79

mmol/l

—

155

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

427

1.40

0.96

5.2

4.1

35.87

41.10

ng/l

0.13

317

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

412

1.38

0.89

2.6

2.4

70.20

78.15

nmol/l

1.60

367

(3022145) Colonoscopy Study observation

130

1.55

0.88

1.3

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.81

0.77

3.0

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2.23

0.77

2.2

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2.23

0.77

1.0

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

871

0.73

0.75

4.8

4.6

1.50

1.28

mmol/l

1.56

794

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.75

0.71

1.4

2.3

—

(42870588) Differential panel, method unspecified - Blood

339

1.33

0.69

9.6

5.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

103

0.56

0.65

14.5

7.8

1.25

1.33

mmol/l

—

103

(3019309) Folate [Moles/volume] in Red Blood Cells

184

1.38

0.65

2.0

1.8

1362.73

1271.10

nmol/l

0.28

141

(3008898) HLA-B27 [Presence]

1.76

0.64

1.0

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

909

0.75

0.61

5.8

5.5

4.50

4.55

mmol/l

0.18

845

(3044640) Blood type and Crossmatch panel - Blood

313

0.74

0.61

2.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.54

0.60

3.7

2.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

187

1.36

0.59

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

2.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.75

0.58

2.5

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.75

0.58

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.66

0.56

3.0

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.66

0.56

2.3

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

223

0.72

0.55

2.9

2.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

135

1.40

0.55

2.2

2.0

—

(3002256) Pathology report gross observation

127

1.40

0.53

1.4

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.53

0.52

1.5

1.9

—

(3023368) Bacteria identified in Blood by Culture

296

1.26

0.49

6.3

4.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.41

0.42

1.1

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.54

0.42

1.8

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.41

0.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.41

0.0

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.41

0.0

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.41

0.0

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

924

0.80

0.41

6.6

6.4

2.58

2.62

mmol/l

0.15

856

(3027008) Opiates [Presence] in Urine

0.00

0.40

0.0

1.3

—

(3016879) Cocaine [Presence] in Urine

0.00

0.40

0.0

1.3

—

(3027944) Amphetamines [Presence] in Urine

0.00

0.40

0.0

1.3

—

(3028300) Cannabinoids [Presence] in Urine

0.00

0.40

0.0

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

5.1

—

110.67

—

(3000764) Benzodiazepines [Presence] in Urine

0.00

0.40

0.0

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

143

1.31

0.40

1.7

1.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1.45

0.40

3.4

2.5

247.40

191.09

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

113

0.69

0.39

4.6

5.1

2.94

47.88

ug/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

904

0.81

0.39

5.5

1.41

1.49

mmol/l

0.98

831

(40768800) Prostate Pathology biopsy report

0.00

0.39

0.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

136

1.29

0.36

1.7

1.4

—

(4035726) Immunohistochemistry procedure

100

1.34

0.35

1.6

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.38

0.35

1.3

1.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

137

1.28

0.34

12.4

5.2

0.97

1.05

mmol/l

0.56

130

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

128

1.29

0.34

1.7

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

553

1.18

0.34

15.0

11.0

4.48

3.96

e9/l

0.86

485

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

984

0.80

0.32

40.0

27.8

41.05

40.15

1.29

975

(3024731) MCV [Entitic mean volume] in Red Blood Cells

984

0.80

0.32

39.4

27.1

91.48

91.86

0.27

977

(3035941) MCH [Entitic mass]

984

0.80

0.32

39.3

27.0

30.21

30.50

0.73

977

(3000963) Hemoglobin [Mass/volume] in Blood

984

0.80

0.32

40.1

27.3

135.21

133.88

g/l

0.40

976

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

0.70

0.32

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1.32

0.31

9.2

2.3

9.47

10.23

g/l

0.43

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.24

0.29

1.7

1.2

—

(3020891) Body temperature

1.24

0.29

3.3

4.3

36.97

36.96

°c

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.25

0.28

1.5

1.7

—

(40761511) CBC panel - Blood by Automated count

933

0.84

0.27

25.2

16.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

179

1.21

0.27

1.5

1.3

12.78

35.72

iu/ml

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1.28

0.25

4.1

2.1

68.16

66.47

g/l

0.34

(3028026) IgM [Mass/volume] in Serum or Plasma

1.22

0.25

2.0

1.5

1.01

1.14

g/l

—

(3019150) Specific gravity of Urine by Refractometry

239

1.17

0.24

4.4

4.3

1.02

kg/l

0.05

154

(3001604) Monocytes [#/volume] in Blood

514

1.13

0.23

9.6

5.9

0.63

0.60

e9/l

0.35

438

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

445

1.13

0.23

2.8

—

estimate

—

(3006315) Basophils [#/volume] in Blood

515

1.13

0.22

9.7

6.0

0.04

e9/l

0.25

438

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

911

1.17

0.22

29.4

18.0

18.53

22.21

mg/l

0.86

783

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.21

0.0

1.6

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.21

0.0

2.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.21

0.0

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

0.00

0.21

0.0

1.3

—

52642.00

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.1

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.21

0.0

2.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

115

0.76

0.21

6.3

9.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.8

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.24

0.20

1.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.3

—

0.20

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.20

0.0

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.20

0.0

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.20

0.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.7

—

(3017732) Neutrophils [#/volume] in Blood

137

1.20

0.20

3.1

3.6

5.72

4.22

e9/l

0.62

117

(3014051) Protein [Presence] in Urine by Test strip

272

1.14

0.19

3.0

2.9

—

0.22

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

974

0.86

0.19

34.1

23.7

81.17

79.58

umol/l

0.17

965

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

520

0.90

0.18

14.0

7.5

1.21

mmol/l

0.32

456

(3019198) Lymphocytes [#/volume] in Blood

520

1.11

0.18

9.6

6.0

1.80

1.98

e9/l

0.54

457

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

0.76

0.17

11.8

2.8

24.20

24.48

mmol/l

—

(21494755) Public health laboratory ask at order entry panel

1.17

0.17

1.6

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1.17

0.17

2.6

2.3

11.51

13.45

nmol/l

—

(3019060) Gas panel - Arterial blood

1.15

0.16

8.9

4.5

—

(36660697) Celiac disease serology panel - Serum

0.77

0.16

1.0

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

227

1.13

0.16

1.6

1.2

0.81

1.38

u/ml

0.47

(3020682) Albumin/Creatinine [Ratio] in Urine

365

1.10

0.15

5.3

3.9

16.53

9.02

mg/mmol

0.26

224

(3000494) Fungus identified in Specimen by Culture

139

0.85

0.15

1.6

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

465

0.91

0.14

2.0

2.2

108.66

96.50

pmol/l

1.55

237

(3013115) Eosinophils [#/volume] in Blood

525

1.09

0.14

10.7

6.2

0.20

e9/l

0.08

456

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1.19

0.13

3.1

2.7

0.19

0.21

g/l

0.35

(3002032) Base excess in Venous blood by calculation

108

0.82

0.13

7.2

3.2

2.26

1.76

mmol/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

171

1.13

0.13

4.2

2.9

1.12

1.01

e6/l

0.07

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

210

1.12

0.13

4.7

3.7

194.26

227.87

ng/l

0.06

168

(3003694) ABO and Rh group [Type] in Blood

240

0.90

0.12

1.6

1.4

—

(40768804) Tissue Pathology biopsy report

401

0.92

0.11

2.8

2.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1.17

0.10

3.8

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.14

0.10

11.0

2.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

411

1.07

0.10

2.5

2.0

1.40

1.34

mmol/l

0.16

345

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

266

0.92

0.08

5.4

4.6

22.89

22.19

0.09

140

(3009508) Creatinine [Moles/volume] in Urine

363

1.07

0.08

3.9

3.1

6.62

7.34

mmol/l

0.66

300

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

0.80

0.08

1.2

2.7

1.35

1.36

g/l

—

(3007164) IgA [Mass/volume] in Serum or Plasma

206

1.08

0.07

1.5

1.3

2.58

2.59

g/l

0.01

114

(3042936) Bacteria identified in Isolate by Culture

157

1.10

0.07

2.9

1.8

—

(40761535) Cells panel - Urine sediment

1.08

0.07

4.9

3.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1.14

0.07

21.4

5.4

11.33

10.03

mmol/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

506

1.05

0.06

2.8

2.7

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

141

0.91

0.05

11.4

8.1

5.58

5.15

kpa

0.44

136

(3027801) Oxygen [Partial pressure] in Arterial blood

141

0.91

0.05

11.4

8.1

12.05

12.13

kpa

0.02

136

(40758558) Short blood count panel - Blood

311

0.95

0.04

14.8

7.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

128

0.93

0.03

2.3

1.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

472

1.03

0.02

14.0

6.5

1.21

mmol/l

0.18

437

(3012516) Albumin [Mass/volume] in Urine

356

0.98

0.00

4.0

3.3

105.69

57.47

mg/l

0.27

231

(3018010) Neutrophils/Leukocytes in Blood

464

1.02

0.00

9.1

6.2

58.46

57.48

0.23

443

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

116

1.04

0.00

2.1

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.01

0.00

1.6

—

(40768797) Stomach Pathology biopsy report

145

1.04

0.00

1.5

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

155

1.04

0.00

4.7

3.0

1.92

3.39

e6/l

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

954

0.98

0.00

31.2

21.4

3.97

4.00

mmol/l

0.43

942

(3019550) Sodium [Moles/volume] in Serum or Plasma

951

0.99

0.00

30.8

21.3

139.98

139.69

mmol/l

0.55

938

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.0

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

44.02

—

(3020491) Glucose [Moles/volume] in Blood

0.00

0.0

3.0

—

6.10

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

4.0

—

3.11

—

(4211845) Urine protein measurement

0.00

0.0

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

12.6

—

933.40

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.00

0.0

1.0

—

7.20

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

9.6

—

8.71

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.0

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

2.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.1

—

(3045788) Cell count panel - Pleural fluid

0.00

0.0

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

4.46

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

69.18

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

-0.00

0.0

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.1

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

0.92

-0.00

9.0

9.4

23.81

24.79

mmol/l

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

10.8

—

0.65

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

24.95

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3051651) Icteric interference index of Serum or Plasma

0.00

-0.00

0.0

3.8

—

0.67

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

0.00

-0.00

0.0

3.4

—

13.96

—

(3014271) Vancomycin [Susceptibility]

0.00

-0.00

0.0

1.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

0.89

-0.00

13.4

8.1

26.79

24.94

mmol/l

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

5.1

—

4.54

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.5

—

16.62

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.00

-0.00

0.0

1.5

—

11.92

—

(3011288) Drugs identified in Urine by Screen method Nominal

0.00

-0.00

0.0

1.4

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

5.1

—

10.86

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

-0.00

0.0

1.7

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

10.7

—

16.79

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

71.21

—

Mortality – FinRegistry

↥

This endpoint is excluded (not available in FinRegistry).

Relationships between endpoints

↥

Index endpoint: PHLEBI_THROMBOP_OTHER_DEEP_VESSE_LOWER_EXTREMITI – Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

GWS hits: -

This endpoint is excluded (not available in FinRegistry).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced (PHLEBI_THROMBOP_OTHER_DEEP_VESSE_LOWER_EXTREMITI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints